ARK Investment Management - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$551,000
+46.5%
10,713
+66.2%
0.11%
-0.9%
Q1 2017$376,000
+97.9%
6,446
+41.5%
0.11%
+56.5%
Q4 2016$190,0004,5550.07%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,710,061$67,074,0101.80%
Bellevue Group AG 4,013,500$99,334,1251.60%
Eagle Health Investments LP 267,630$6,623,8431.46%
ARMISTICE CAPITAL, LLC 3,324,000$82,269,0001.26%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$11,236,5000.61%
Frazier Life Sciences Management, L.P. 292,002$7,227,0500.48%
ArrowMark Colorado Holdings LLC 1,573,359$38,940,6350.47%
Deep Track Capital, LP 422,247$10,450,6130.40%
FARALLON CAPITAL MANAGEMENT LLC 2,750,829$68,083,0180.34%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 24,000$593,5200.20%
View complete list of AGIOS PHARMACEUTICALS INC shareholders